In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Internal Medicine"
DOI: 10.7326/acpj202111160-125
Abstract: SOURCE CITATION WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis.… read more here.
Keywords: tocilizumab reduces; reduces mortality; covid tocilizumab; hospitalized covid ... See more keywords